B. Paul Morgan
University of Notre Dame(US)Iowa State University(US)UK Dementia Research Institute(GB)Cytokinetics (United States)(US)University of Wales Institute Cardiff(SG)Institute of Infection and Immunity(CA)Cardiff University(GB)Cardiff Metropolitan University(GB)University of Wales(GB)
Publications by Year
Research Areas
Complement system in diseases, Monoclonal and Polyclonal Antibodies Research, Erythrocyte Function and Pathophysiology, Neuroinflammation and Neurodegeneration Mechanisms, Blood groups and transfusion
Most-Cited Works
- → Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference(2016)680 cited
- → C3 glomerulopathy: consensus report(2013)627 cited
- → Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure(2011)591 cited
- Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.(1990)
- → IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†(2008)510 cited
- → Immunopathology of secondary‐progressive multiple sclerosis(2001)449 cited
- → Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome